PRTA

NASDAQStock

Prothena Corporation plc

$9.26-0.05 (-0.54%)

52-Week Range

$4.58

$13.74

Key Stats

Market Cap

498.5M

P/E Ratio

—

Dividend Yield

—

Beta

-0.28

Volume

387.1K

Avg Volume

590.8K

Performance

+5.20%

-6.62%

+14.09%

YTD

+1.20%

-32.24%

-81.01%

-62.37%

Price Chart

ETF Exposure

PRTA is held by 58 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$50	$9.3M	0.12%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,073	$10K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,073	$10K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,073	$10K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,073	$10K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,073	$10K	$3.7M	0.70%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	51,039	$38K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	51,039	$12K	$3.91B	0.07%

PreviousPage 2 of 2

About PRTA ETF Exposure

Prothena Corporation plc (PRTA) is held by 58 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 498.5M, PRTA is a widely held institutional stock. The stock currently trades at $9.26. Investors can gain exposure to PRTA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PRTA, sorted by portfolio weight.